Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
5.50
-0.03 (-0.54%)
At close: Jun 9, 2026, 4:00 PM EDT
5.45
-0.05 (-0.91%)
After-hours: Jun 9, 2026, 7:53 PM EDT
Plus Therapeutics Employees
Plus Therapeutics had 28 employees as of December 31, 2025. The number of employees increased by 7 or 33.33% compared to the previous year.
Employees
28
Change (1Y)
7
Growth (1Y)
33.33%
Revenue / Employee
$185,071
Profits / Employee
-$426,107
Market Cap
37.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | 7 | 33.33% |
| Dec 31, 2024 | 21 | 1 | 5.00% |
| Dec 31, 2023 | 20 | 3 | 17.65% |
| Dec 31, 2022 | 17 | 3 | 21.43% |
| Dec 31, 2021 | 14 | 2 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| aTyr Pharma | 60 |
| ABVC BioPharma | 19 |
| RenovoRx | 17 |
| Atossa Therapeutics | 16 |
| Nutriband | 13 |
| Hyperion DeFi | 9 |
| Genenta Science | 9 |
PSTV News
- 4 days ago - Plus Therapeutics Registration statement: Registration filing - Filings
- 5 days ago - Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory - GlobeNewsWire
- 7 days ago - Plus Therapeutics Registration statement: Registration filing - Filings
- 7 days ago - Plus Therapeutics files $100M mixed securities shelf - TheFly
- 14 days ago - Plus announces presentation of health economics study on CNSide CSF assay - TheFly
- 14 days ago - Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases - GlobeNewsWire
- 21 days ago - Plus Therapeutics enters pact with Ephemeral for AI execution platform - TheFly
- 21 days ago - Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology - GlobeNewsWire